Botox-maker Allergan sees profits drop slightly in third quarter

Allergan, the maker of anti-wrinkle treatment Botox, saw profits slightly lower in the third quarter.

The company which employs close to 1,000 people in Westport, Co Mayo, posted a profit of $249.4m, or 82 cents per share, in the third quarter compared with $249.8m (€194m), or 81 cents per share, a year earlier.

Allergan also said it was exploring a sale of its obesity business on falling sales of the only product in the unit.